FDA Inspection 1030229 — Chartwell Pharmaceuticals West Caldwell LLC

Chartwell Pharmaceuticals West Caldwell LLC — FEI 3005376609

The FDA completed an inspection of Chartwell Pharmaceuticals West Caldwell LLC on Sep 18, 2017 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Caldwell, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.